Skip navigation

Uniting Payers, Providers and Manufacturers to Increase Market Access and Identify Value Ecosystems for Mature and Emerging Oncologic Therapies

February 28-March 1, 2018
  • San Francisco, CA

The Industry’s Longest-Running Oncology Market Access Event is Back!

CBI’s 11th Annual Oncology Market Access Strategy Summit convenes key stakeholders involved in commercializing new-to-market drugs and refreshing mature therapeutics. From manufacturers and payers, to healthcare providers, join your industry counterparts as they benchmark best practices to streamline market access and promote commercial success.

As the marketplace makes room for new and diverse treatment options, it is more important than ever to have a clear “go-to-market strategy” for oncology therapies. Today’s crowded marketplace and slim margins expose manufacturers to poor market performance and commercial failure if a well-developed market access strategy is not executed.

This year’s Oncology Market Access Strategy Summit ensures manufacturers have the tools needed to identify value networks early in the product lifecycle and confirm proper reimbursement channels are in place. Featuring panels, workshops, networking opportunities and more, this interactive conference provides answers to your company’s specific issues in this competitive industry, including:

  • Understanding Payer and Pharma Perspectives
  • Developing pricing models to encourage reimbursement
  • Navigating combination therapy reimbursement
  • Planning for the disruptive influence of biosimilars
  • Pre-Launch Strategy Planning
  • Managing product lifecycle from approval to retirement
  • Understanding oncologic clinical pathways

Download the Conference Preview

PREVIOUS ATTENDEE ACCLAIM:

This conference has a great line-up of speakers and the conference atmosphere enabled excellent discussion

Global Head, Pricing, Market Access & Policy, Biosimilars, Merck

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today
by manufacturers utilizing co-pay off-set strategies

VP, Industry Relations & Managed Markets, City Drugs Specialty Pharmacy

Excellent appraisal of approaches and philosophies in market access and engagement

Senior Director, Quality Strategic Consumer Group, Janssen

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think of new approaches to explore during the year

Assistant Director, Payer Marketing, Acorda Therapeutics

11th Annual Oncology Market Access Strategy Summit

Uniting Payers, Providers and Manufacturers to Increase Market Access and Identify Value Ecosystems for Mature and Emerging Oncologic Therapies

The Industry’s Longest-Running Oncology Market Access Event is Back!

CBI’s 11th Annual Oncology Market Access Strategy Summit convenes key stakeholders involved in commercializing new-to-market drugs and refreshing mature therapeutics. From manufacturers and payers, to healthcare providers, join your industry counterparts as they benchmark best practices to streamline market access and promote commercial success.

As the marketplace makes room for new and diverse treatment options, it is more important than ever to have a clear “go-to-market strategy” for oncology therapies. Today’s crowded marketplace and slim margins expose manufacturers to poor market performance and commercial failure if a well-developed market access strategy is not executed.

This year’s Oncology Market Access Strategy Summit ensures manufacturers have the tools needed to identify value networks early in the product lifecycle and confirm proper reimbursement channels are in place. Featuring panels, workshops, networking opportunities and more, this interactive conference provides answers to your company’s specific issues in this competitive industry, including:

  • Understanding Payer and Pharma Perspectives
  • Developing pricing models to encourage reimbursement
  • Navigating combination therapy reimbursement
  • Planning for the disruptive influence of biosimilars
  • Pre-Launch Strategy Planning
  • Managing product lifecycle from approval to retirement
  • Understanding oncologic clinical pathways

Download the Conference Preview

PREVIOUS ATTENDEE ACCLAIM:

This conference has a great line-up of speakers and the conference atmosphere enabled excellent discussion

Global Head, Pricing, Market Access & Policy, Biosimilars, Merck

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today
by manufacturers utilizing co-pay off-set strategies

VP, Industry Relations & Managed Markets, City Drugs Specialty Pharmacy

Excellent appraisal of approaches and philosophies in market access and engagement

Senior Director, Quality Strategic Consumer Group, Janssen

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think of new approaches to explore during the year

Assistant Director, Payer Marketing, Acorda Therapeutics